Clay B. Siegall - Jan 31, 2025 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
President and CEO, Director
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
Stock symbol
IMNM
Transactions as of
Jan 31, 2025
Transactions value $
$1,162,500
Form type
4
Date filed
2/3/2025, 09:01 PM
Previous filing
Nov 25, 2024
Next filing
Mar 26, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMNM Common Stock Purchase $1.16M +150K +28.87% $7.75 670K Jan 31, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person purchased the shares in connection with the Issuer's recently completed underwritten public offering of common stock.